APA (7th ed.) Citation

Yesilöz, U., Kirches, E., Hartmann, C., Scholz, J., Kropf, S., Sahm, F., . . . Mawrin, C. (2017). Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence. Neuro-Oncology, 19(8), . https://doi.org/10.1093/neuonc/nox018

Chicago Style (17th ed.) Citation

Yesilöz, Ümmügülsüm, Elmar Kirches, Christian Hartmann, Johannes Scholz, Siegfried Kropf, Felix Sahm, Makoto Nakamura, and Christian Mawrin. "Frequent AKT1E17K Mutations in Skull Base Meningiomas Are Associated with MTOR and ERK1/2 Activation and Reduced Time to Tumor Recurrence." Neuro-Oncology 19, no. 8 (2017). https://doi.org/10.1093/neuonc/nox018.

MLA (9th ed.) Citation

Yesilöz, Ümmügülsüm, et al. "Frequent AKT1E17K Mutations in Skull Base Meningiomas Are Associated with MTOR and ERK1/2 Activation and Reduced Time to Tumor Recurrence." Neuro-Oncology, vol. 19, no. 8, 2017, https://doi.org/10.1093/neuonc/nox018.